• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

Budesonide

Product ID B8112
Cas No. 51333-22-3
Purity ≥97%
Product Unit SizeCostQuantityStock
100 mg $89.40 In stock
250 mg $255.40 In stock
1 g $715.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Budesonide is a corticosteroid with strong glucocorticoid and weak mineralocorticoid characteristics. Budesonide exhibits anti-inflammatory and anti-asthma activities and is used clinically to treat Crohn’s disease, inflammatory bowel disease (IBD), and chronic obstructive pulmonary disorder (COPD). In animal models, budesonide induces pulmonary vasoconstriction. Budesonide inhibits expression of IL-32 in lungs and improves pulmonary function in animal models of cigarette smoking-induced COPD. Additionally, budesonide decreases TGF-β1-induced VEGF secretion and activation of ERK and Smad3 in lung fibroblasts. Budesonide also induces DNA hypermethylation.

Product Info

Cas No.

51333-22-3

Purity

≥97%

Formula

C25H34O6

Formula Wt.

430.53

Melting Point

226°C

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

B8112 MSDS PDF

Info Sheet

B8112 Info Sheet PDF

References

Deng X, Zhang Z, Gu W, et al. Budesonide inhibits interleukin-32 expression in a rat model of chronic obstructive pulmonary disease. Exp Lung Res. 2012 Aug;38(6):295-301. PMID: 22646473.

Orta ML, Domínguez I, Pastor N, et al. The role of the DNA hypermethylating agent Budesonide in the decatenating activity of DNA topoisomerase II. Mutat Res. 2010 Dec 10;694(1-2):45-52. PMID: 20883705.

Chen YJ, Wang T, Liu DS, et al. Effect of budesonide on TGF-beta1-enhanced VEGF production by lung fibroblasts. Cell Biol Int. 2010 Jul;34(7):777-82. PMID: 20359293.

Ewing P, Ryrfeldt A, Sjöberg CO, et al. Vasoconstriction after inhalation of budesonide: a study in the isolated and perfused rat lung. Pulm Pharmacol Ther. 2010 Feb;23(1):9-14. PMID: 19800019.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only